NL
DE
The aim of the PRECISE biobank is to develop the first, smart multi-modal liquid biopsy test service for the prediction of immune checkpoint inhibitor response in urothelial cancer (UC) patients – the PRECISE IVD. The biobank contains biomaterial (PBMCs, cfDNA and PAXgene) and clinical data from patients with metastatic UC in whom treatment with anti-PD-(L)1 has been initiated.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Process and time constraints for external sample issuance
6 May 2025Prior to issuing samples intended for an external applicant, the Radboud Biobank first draws up a quotation of the expected costs. This process will lead to some delays in distribution.
read more
Periodic invoicing biobank collections
6 May 2025As of this year, the Radboud Biobank will periodically charge biobank collections for the processing and storage costs incurred.
read more
National Biobanks & Collections Dag 2025
6 May 2025The second edition of the National Biobanks & Collections Day took place on March 27, 2025, in Nijmegen and attracted 150 participants from all over the Netherlands.
read moreRadboud Biobank Office Relocation
30 January 2025We would like to inform you about the upcoming relocation of the Radboud Biobank office.
read more
Request for DNA samples from stored whole blood and/or saliva
30 January 2025There are biobank collections that collected whole blood and saliva before joining the Radboud Biobank to isolate DNA from them later.
read more
Great news!
30 January 2025We have good news for both new and existing collections and projects interested in isolating PBMCs (Peripheral Blood Mononuclear Cells)!
read more